These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31907722)

  • 1. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
    Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
    Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis.
    Peacock O; Smith N; Waters PS; Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
    Colorectal Dis; 2020 Jul; 22(7):818-823. PubMed ID: 31961476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
    Khan O; Patsouras D; Ravindraanandan M; Abrar MM; Schizas A; George M; Malde S; Thurairaja R; Khan MS; Sahai A
    Eur Urol Focus; 2021 May; 7(3):638-643. PubMed ID: 32622667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy.
    Aslim EJ; Chew MH; Chew GK; Lee LS
    ANZ J Surg; 2018 Sep; 88(9):896-900. PubMed ID: 29895098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
    Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
    Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
    Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
    Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
    Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
    J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
    Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
    ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
    Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary diversion after total pelvic exenteration for rectal cancer.
    Russo P; Ravindran B; Katz J; Paty P; Guillem J; Cohen AM
    Ann Surg Oncol; 1999 Dec; 6(8):732-8. PubMed ID: 10622500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.